DBV TECHNOLOGIES Aktie 2857349 / FR0010417345
0.65
EUR
-0.01
EUR
-1.65%
10.12.2024
PAR
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
DBV TECHNOLOGIES Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | DBV TECHNOLOGIES | 0.00 | 0.00 | EUR |
| 2022 | DBV TECHNOLOGIES | 0.00 | 0.00 | EUR |
| 2021 | DBV TECHNOLOGIES | 0.00 | 0.00 | EUR |
| 2020 | DBV TECHNOLOGIES | 0.00 | 0.00 | EUR |
| 2019 | DBV TECHNOLOGIES | 0.00 | 0.00 | EUR |
| 2018 | DBV TECHNOLOGIES | 0.00 | 0.00 | EUR |
| 2017 | DBV TECHNOLOGIES | 0.00 | 0.00 | EUR |
| 2016 | DBV TECHNOLOGIES | 0.00 | 0.00 | EUR |
| 2015 | DBV TECHNOLOGIES | 0.00 | 0.00 | EUR |
| 2014 | DBV TECHNOLOGIES | 0.00 | 0.00 | EUR |
Zu diesem Datensatz liegen uns leider keine Daten vor.
DBV TECHNOLOGIES Termine
| Unternehmen | Event | Datum |
|---|---|---|
| DBV TECHNOLOGIES | Quartalszahlen | 06.03.2025 |
| DBV TECHNOLOGIES | Quartalszahlen | 01.05.2025 |
| DBV TECHNOLOGIES | Quartalszahlen | 04.08.2025 |
| DBV TECHNOLOGIES | Quartalszahlen | 30.10.2025 |
DBV TECHNOLOGIES vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 06.11.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 30.07.2024 |
| Hauptversammlung | Annual General Meeting | 16.05.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 07.05.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 07.03.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 31.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 31.07.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 04.05.2023 |
| Hauptversammlung | Annual General Meeting | 12.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 02.03.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 03.11.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 01.08.2022 |
| Hauptversammlung | Annual General Meeting | 12.05.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 02.05.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 03.03.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 83.73 |
| Venrock Associates | 9.07 |
| BPIFrance Investissement SAS | 6.98 |
| Bpifrance Participations SA /PRIVATE EQUITY/ | 6.76 |
| Braidwell LP | 6.51 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 242 | 315 | 319 | 141 | 92 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bilanz (in Mio. EUR) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 157 | 145 | 182 | 169 | 101 |
| Summe Anlagevermögen | 20 | 26 | 58 | 53 | 28 |
| Summe Aktiva | 176 | 171 | 240 | 223 | 129 |
Bilanz (in Mio. EUR) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 48 | 50 | 70 | 55 | 42 |
| Summe Eigenkapital | 129 | 121 | 171 | 168 | 87 |
| Summe Passiva | 176 | 171 | 240 | 223 | 129 |
Adresse
| 107 avenue de la Republique, 92320 Chatillon | |
| Telefon | +33 (1) 55-42-78-78 |
| Fax | +33 (1) 43-26-10-83 |
| URL | http://www.dbv-technologies.com |
Management
|
Adora Ndu
Independent Director |
|
Caroline Daniere
Chief Human Resources Officer & Chief of Staff |
|
Daniel B. Soland
Independent Director |
|
Daniel Tassé
Chief Executive Officer & Executive Director |
|
Danièle Guyot-Caparros
Independent Director |
|
Julie O'Neill
Independent Director |
|
Katie Matthews
Investor Relations Contact |
|
Kevin P. Malobisky
Chief Operations Officer |
|
Maïlys Ferrère
Director |
|
Michael J. Goller
Director |
|
Michel de Rosen
Independent Non-Executive Chairman |
|
Michele F. Robertson
Chief Legal Officer |
|
Pascal Wotling
Chief External Manufacturing Officer |
|
Pascale Ehouarn
Chief Engineering, Manufacturing & Supply Officer |
|
Pharis Mohideen
Chief Medical Officer |
|
Ravi Madduri Rao
Independent Director |
|
Timothy E. Morris
Independent Director |
|
Virginie Simone Jeanine Verrechia
Chief Financial Officer |